New data for Roche’s Ocrevus show benefit in disability progression and cognitive decline in secondary progressive and primary progressive multiple sclerosis Read more
US FDA grants priority review to Roche’s Actemra/RoActemra to treat COVID-19 in hospitalised adults Read more
CHMP recommends EU approval of Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma Read more
Roche’s Faricimab improves and maintains vision in two leading causes of vision loss: Lancet Read more
European Commission approves Roche’s Gavreto to treat adults with RET fusion-positive advanced non-small cell lung cancer Read more